v3 Template
B

Beactica Therapeutics AB

Biotechnology / Precision Medicine ~280 employees
Founded
--
Employees (Est.)
~280
14 leaders known
Total Funding
$2.5M
Funding Rounds
1
Last Funding
2026-02-17

About Beactica Therapeutics AB

Beactica Therapeutics is a precision medicine company focused on developing novel small molecule therapeutics to treat life-threatening diseases with significant unmet clinical needs.

Products & Services

Eclipsor™ Platform:A platform that synergizes across allosteric modulation and targeted protein degradation to address 'undruggable' proteins.
Targeted Protein Degradation Solutions:Breakthrough solutions aimed at specifically and effectively targeting disease-generating proteins.

Specialties

Precision Medicine Small Molecule Therapeutics Targeted Protein Degradation (TPD) Allosteric Modulation Drug Discovery for Undruggable Targets

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant 		A: 2500000
MR: -
FA: EUR 2.5 million
FAN: 2500000 		D: 2026-02-17
FD: 2026-02-17 		1 investors
Grant Latest
2026-02-17
$2.5M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

P

Per Källblad

Chief Executive Officer

K

Konrad Koehler

Head of Discovery

P

Peter Brandt

Head of Chemistry

J

Johan Winquist

Head of Operations

A

Anneli Hällgren

Preclinical Development

C

Carl-Magnus Andersson

Ph.D.

View 11 more team members with Pro

Unlock Full Team Directory

Recent News

Beactica Therapeutics AB Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Precision Medicine
Company Size
~280 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro